UBS Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,057
| Closed | -$1.01K | – | 9022 |
|
|
2023
Q1 | $1.01K | Sell |
3,057
-453
| -13% | -$150 | ﹤0.01% | 7753 |
|
|
2022
Q4 | $2.53K | Buy |
+3,510
| New | +$2.53K | ﹤0.01% | 8465 |
|
|
2022
Q3 | – | Sell |
-2,422
| Closed | -$3K | – | 10135 |
|
|
2022
Q2 | $3K | Sell |
2,422
-249
| -9% | -$308 | ﹤0.01% | 8400 |
|
|
2022
Q1 | $6K | Sell |
2,671
-4,303
| -62% | -$9.67K | ﹤0.01% | 7984 |
|
|
2021
Q4 | $10K | Buy |
6,974
+5,502
| +374% | +$7.89K | ﹤0.01% | 7713 |
|
|
2021
Q3 | $4K | Sell |
1,472
-4,437
| -75% | -$12.1K | ﹤0.01% | 7579 |
|
|
2021
Q2 | $20K | Sell |
5,909
-98
| -2% | -$332 | ﹤0.01% | 6270 |
|
|
2021
Q1 | $23K | Sell |
6,007
-3,202
| -35% | -$12.3K | ﹤0.01% | 6239 |
|
|
2020
Q4 | $32K | Buy |
9,209
+1,181
| +15% | +$4.1K | ﹤0.01% | 5581 |
|
|
2020
Q3 | $53K | Sell |
8,028
-2,341
| -23% | -$15.5K | ﹤0.01% | 4762 |
|
|
2020
Q2 | $77K | Buy |
10,369
+2,094
| +25% | +$15.6K | ﹤0.01% | 4693 |
|
|
2020
Q1 | $39K | Buy |
8,275
+3,933
| +91% | +$18.5K | ﹤0.01% | 5132 |
|
|
2019
Q4 | $56K | Buy |
4,342
+690
| +19% | +$8.9K | ﹤0.01% | 5243 |
|
|
2019
Q3 | $38K | Buy |
3,652
+1,814
| +99% | +$18.9K | ﹤0.01% | 5405 |
|
|
2019
Q2 | $31K | Sell |
1,838
-382
| -17% | -$6.44K | ﹤0.01% | 5448 |
|
|
2019
Q1 | $74K | Sell |
2,220
-2,146
| -49% | -$71.5K | ﹤0.01% | 4488 |
|
|
2018
Q4 | $128K | Buy |
4,366
+2,487
| +132% | +$72.9K | ﹤0.01% | 4459 |
|
|
2018
Q3 | $115K | Buy |
1,879
+206
| +12% | +$12.6K | ﹤0.01% | 4622 |
|
|
2018
Q2 | $124K | Buy |
1,673
+1,171
| +233% | +$86.8K | ﹤0.01% | 4419 |
|
|
2018
Q1 | $33K | Sell |
502
-26
| -5% | -$1.71K | ﹤0.01% | 5164 |
|
|
2017
Q4 | $44K | Sell |
528
-1,009
| -66% | -$84.1K | ﹤0.01% | 4994 |
|
|
2017
Q3 | $178K | Buy |
1,537
+466
| +44% | +$54K | ﹤0.01% | 4082 |
|
|
2017
Q2 | $125K | Buy |
1,071
+931
| +665% | +$109K | ﹤0.01% | 4158 |
|
|
2017
Q1 | $17K | Buy |
140
+44
| +46% | +$5.34K | ﹤0.01% | 5359 |
|
|
2016
Q4 | $13K | Sell |
96
-244
| -72% | -$33K | ﹤0.01% | 5821 |
|
|
2016
Q3 | $68K | Buy |
340
+100
| +42% | +$20K | ﹤0.01% | 4406 |
|
|
2016
Q2 | $31K | Buy |
240
+170
| +243% | +$22K | ﹤0.01% | 5046 |
|
|
2016
Q1 | $7K | Buy |
70
+20
| +40% | +$2K | ﹤0.01% | 6015 |
|
|
2015
Q4 | $10K | Sell |
50
-149
| -75% | -$29.8K | ﹤0.01% | 6006 |
|
|
2015
Q3 | $29K | Buy |
199
+149
| +298% | +$21.7K | ﹤0.01% | 5143 |
|
|
2015
Q2 | $11K | Sell |
50
-69
| -58% | -$15.2K | ﹤0.01% | 5931 |
|
|
2015
Q1 | $28K | Sell |
119
-1,602
| -93% | -$377K | ﹤0.01% | 5110 |
|
|
2014
Q4 | $397K | Buy |
+1,721
| New | +$397K | ﹤0.01% | 3337 |
|